Vasconcellos E, Wyllie E, Sullivan S, Stanford L, Bulacio J, Kotagal P, Bingaman W
Department of Neurology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, U.S.A.
Epilepsia. 2001 Feb;42(2):268-74. doi: 10.1046/j.1528-1157.2001.12200.x.
We sought to determine whether early age at seizure onset is a risk factor for mental retardation, independent of etiology. Assessment of risk for mental retardation with continued uncontrolled seizures plays a role in considerations of timing for epilepsy surgery. Previous studies have indicated that onset of seizures in the first years of life may be a risk factor for mental retardation, but the etiologies of the epilepsies were not included in the analyses.
Intellectual function was assessed at ages 2-20 years during presurgical evaluation in 100 patients with intractable epilepsy due to focal lesions limited to part of one lobe of the brain. Mental retardation (MR) was defined as Full-Scale Intelligence Quotient (FSIQ) < or =70. The age at seizure onset and the seizure frequency were obtained retrospectively.
Younger ages at seizure onset were associated with lower FSIQ scores, and mean FSIQ was also significantly lower for patients with onset of epilepsy at < or =24 months of age (74.0 +/- 21.5) versus that in patients with onset of epilepsy later in life (87.8 +/- 18.8; p = 0.005). The frequency of patients with MR was significantly higher for patients with seizure onset at < or =24 months of age (15 of 33, 46%) than for patients with seizure onset later in life (eight of 67, 12%; p < 0.001). This difference persisted within etiologic subgroups. For patients with focal malformation of cortical development, MR was seen in eight (50%) of 16 patients with seizure onset at < or =24 months versus two (10%) of 20 patients with seizure onset at >24 months (p < 0.001); for patients with tumor, MR was seen in four (50%) of eight patients with seizure onset at < or =24 months versus four (13%) of 30 patients with seizure onset at >24 months (p = 0.003); and for patients with hippocampal sclerosis, MR was seen in two (28%) of seven patients with seizure onset at < or =24 months versus none of 30 patients with seizure onset at >24 months (NS). Within the subgroup with daily seizures, MR was present in 13 (65%) of 20 patients with seizure onset at < or =24 months versus five (17%) of 29 patients with seizure onset later in life (p = 0.001).
These results indicate that onset of intractable epilepsy within the first 24 months of life is a significant risk factor for MR, especially if seizures occur daily. The risk based on early age at seizure onset appeared independent of etiology and persisted within subgroups of patients with focal malformation of cortical development, tumor, or hippocampal sclerosis. Prospective studies will be important to clarify whether early surgical intervention may reduce the risk for subsequent MR in carefully selected infants.
我们试图确定癫痫发作的早期年龄是否是智力发育迟缓的一个危险因素,而不考虑病因。评估持续未得到控制的癫痫发作导致智力发育迟缓的风险,对于癫痫手术时机的考量具有重要意义。既往研究表明,在生命的最初几年出现癫痫发作可能是智力发育迟缓的一个危险因素,但这些分析未纳入癫痫的病因。
对100例因局限于一侧脑叶部分的局灶性病变导致的难治性癫痫患者进行术前评估,在2至20岁时评估其智力功能。智力发育迟缓(MR)定义为全量表智商(FSIQ)≤70。回顾性获取癫痫发作的年龄和发作频率。
癫痫发作年龄越小,FSIQ得分越低,癫痫发作年龄≤24个月的患者平均FSIQ(74.0±21.5)显著低于癫痫发作年龄较大的患者(87.8±18.8;p = 0.005)。癫痫发作年龄≤24个月的患者中智力发育迟缓患者的比例(33例中的15例,46%)显著高于癫痫发作年龄较大的患者(67例中的8例,12%;p < 0.001)。这种差异在病因亚组中持续存在。对于皮质发育局灶性畸形患者,癫痫发作年龄≤24个月的16例患者中有8例(50%)出现智力发育迟缓,而癫痫发作年龄>24个月的20例患者中有2例(10%)出现智力发育迟缓(p < 0.001);对于肿瘤患者,癫痫发作年龄≤24个月的8例患者中有4例(50%)出现智力发育迟缓,而癫痫发作年龄>24个月的30例患者中有4例(13%)出现智力发育迟缓(p = 0.003);对于海马硬化患者,癫痫发作年龄≤24个月的7例患者中有2例(28%)出现智力发育迟缓,而癫痫发作年龄>24个月的30例患者中无一例出现智力发育迟缓(无显著性差异)。在每日发作的亚组中,癫痫发作年龄≤24个月的20例患者中有13例(65%)出现智力发育迟缓,而癫痫发作年龄较大的29例患者中有5例(17%)出现智力发育迟缓(p = 0.001)。
这些结果表明,在生命的前24个月内出现难治性癫痫发作是智力发育迟缓的一个重要危险因素,尤其是如果癫痫每日发作。基于癫痫发作早期年龄的风险似乎与病因无关,并且在皮质发育局灶性畸形、肿瘤或海马硬化患者亚组中持续存在。前瞻性研究对于明确早期手术干预是否可以降低精心挑选的婴儿后续出现智力发育迟缓的风险将具有重要意义。